Medical management of obstructive sleep apnea

Progress in Cardiovascular Diseases

Volumn 41, Issue 5, 1999, Pages 377-386

  Henderson II, James H ^b   Strollo Jr , Patrick J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREATHING DISORDER; CONSERVATIVE TREATMENT; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PATIENT POSITIONING; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; SLEEP APNEA SYNDROME; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 0033001407     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.1999.0410377     Document Type: Article

References (109)

1. Millman RP, Redline S, Carslisle C, et al. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing factors. Chest. 99:1991;861-866
2. Hla KM, Young TB, Palta M, et al. Sleep apnea and hypertension. Ann Intern Med. 120:1994;382-388
3. Weitzenblum E, Krieger J, Apprill M, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Repir Dis. 138:1988;345-349
4. Sajkov D, Cowie RJ, Thornton AT, et al. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 149:1994;416-422
5. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest. 97:1990;27-32
6. Shepard JW. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med. 13:1995;437-458
7. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrythmia and conductance disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 52:1983;490-494
8. Wright J, Johns R, Watt I, et al. Health effects of obstructive sleep apnea and the effectiveness of continuous positive airway pressure: A systematic review of the search evidence. BMJ. 314:1997;851-860
9. Stradling J. Sleep apnea and the misuse of evidence-based medicine. Lancet. 349:1997;201-202
10. Engleman H. Self-reported use of CPAP and benefits of CPAP therapy. Chest. 16:1993;678-680
11. Strollo PJ, Sanders MH, Atwood CW. Positive pressure therapy. Clin Chest Med. 19:1998;55-68
12. Bradley TD, Brown JG, Grossman RF, et al. Pharyngeal size in snorers, nonsnorers, and patients with obstructive sleep apnea. N Engl J Med. 315:1986;1327-1331
13. Schwab RJ, Gefter WB, Hoffman EA, et al. Dynamic upper airway imaging during respiration in normal subjects and patients with sleep disordered breathing. Am Rev Respir Dis. 148:1993;1385-1400
14. Hudgel DW. Mechanisms of obstructive sleep apnea. Chest. 101:1992;541-549
15. Horner RL, Mohiaddin RH, Lowell DG, et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnea and weight matched controls. Eur Respir J. 2:1989;613-622
16. Shelton KE, Gay SB, Woodson H, et al. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis. 148:1993;462-466
17. Schwab RJ, Gupta KB, Geffer WB, et al. Upper airway soft tissue anatomy in normals and patients with sleep disordered breathing. Am J Respir Crit Care Med. 152:1995;1673-1689
18. Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med. 103:1985;850-855
19. Philips BA, Anstead MI, Pinto SJ. Behavioral management of obstructive sleep apnea. Sem Resp Crit Care Med. 19:1998;139-146
20. Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: A critical review. Sleep. 19:1996;104-115
21. Pillar G, Peled R, Lavie P. Recurrence of sleep apnea without concommitant weight increase 7.5 years after weight reduction surgery. Chest. 106:1994;1702-1704
22. Kiselak J, Clark M, Pera V, et al. The association between hypertension and sleep apnea in obese patients. Chest. 104:1993;775-780
23. Suratt PM, McTier RF, Findley LJ, et al. Effect of very-low-calorie-diets with weight loss on obstructive sleep apnea. Am J Clin Nutr. 56:1992;1825-1845
24. Lojander J, et al. A nurse-managed weight reduction program for obstructive sleep apnea syndrome. J Intern Med. 244:1998;251-255
25. Weintraub M. Long-term weight control study: Conclusions. Clin Pharmacol Ther. 51:1992;642-646
26. Strobel R, Lewin D, Rosen R, et al. Fenfluramine hydrochloride-assisted weight loss in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 149:1994;A495. (abstr)
27. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 335:1996;609-619
28. Khan MA, Herzog CA, St. Peter JV, et al. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med. 339:1998;713-718
29. Connolly H, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 337:1997;581-588
30. Peiser J, Lavie P, Ovnat A, et al. Sleep apnea in the morbidly obese as an indication for weight reduction surgery. Ann Surg. 199:1984;112-112
31. Rubenstein I, Colapinto N, Rotstein E, et al. Improvement in upper airway function after weight loss in patients with obstructive sleep apnea. Am Rev Respir Dis. 138:1988;1192-1195
32. Bonora M, Shields GI, Knuth SL, et al. Selective depression by ethanol of upper airway respiratory motor activity. Am Rev Respir Dis. 130:1984;156-161
33. Bonora M, St. John WM, Bledsoe TA. Differential elevation by protryptaline and depression by diazepam for upper airway respiratory motor activity. Am Rev Respir Dis. 131:1985;41-45
34. Issa FG, Sullivan CE. Alcohol, snoring, and sleep apnea. J Neurol Neurosurg Psychiatry. 45:1982;353-359
35. Cartwright R. Effect of sleep position on sleep apnea severity. Sleep. 7:1984;110-114
36. Cartwright R, Lloyd S, Lilie J, et al. Sleep position training as treatment for sleep apnea syndrome: a preliminary study. Sleep. 8:1985;87-94
37. Cartwright R, Ristanovic R, Diaz F, et al. A comparative study of treatments for positional sleep apnea. Sleep. 14:1991;546-552
38. McEvoy RD, Sharp DJ, Thornton A. The effects of posture on obstructive sleep apnea. Am Rev Respir Dis. 133:1986;662-666
39. Fletcher EC, Munafo DA. Role of nocturnal oxygen therapy in obstructive sleep apnea: When should it be used? Chest. 98:1990;1497-1504
40. Colt HG, Haas H, Rich GB. Hypoxemia vs sleep fragmentation as cause of excessive daytime sleepiness in obstructive sleep apnea. Chest. 100:1991;1542-1548
41. Aljadeff G, Gozal D, Bailey-Wahl SL, et al. Effects of overnight supplemental oxygen in obstructive sleep apnea in children. Am J Respir Crit Care Med. 153:1996;51-55
42. Hudgel DW, Thanakitcharu S. Pharmacologic treatment of sleep-disordered breathing. Am J Respir Crit Care Med. 158:1998;691-699
43. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protripyline. Chest. 100:1991;491-494
44. Brownell LG, West P, Sweatman P, et al. Protriptyline in obstructive sleep apnea, a double-blind trial. N Engl J Med. 307:1982;1037-1042
45. Smith PL, Haponik EF, Allen RP, et al. The effects of protripyline in sleep-disordered breathing. Am Rev Respir Dis. 127:1983;8-13
46. Kraiczi H, Dahlof P, Carlson J, et al. Paroxetine reduces sleep disordered breathing in obstructive sleep apnea patients. Am J Respir Crit Care Med. 155:1997;C47. (abstr)
47. Mendelson WB, Maczaj M, Holt J. Buspirone administration to sleep apnea patients. J Clin Psychopharmacol. 11:1991;71-72
48. Strollo PJ, Rogers RM. Obstructive sleep apnea. N Engl J Med. 334:1996;99-104
49. Skatrud JB, Dempsey JA, Kaiser DJ. Ventilatory response to medroxyprogesterone acetate in normal subjects: Time course and mechanism. J Appl Physiol. 44:1978;939-944
50. Block AJ, Wynne JM, Boysen PG, et al. Menopause, medroxyprogesterone, and breathing during sleep. Am J Med. 70:1981;506-510
51. Rajagopal KR, Abbrecht PH, Jabbari B. Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest. 96:1986;262-266
52. Strohl KP, Hensley NJ, Saunders NA, et al. Progesterone administration and progressive sleep apnea. JAMA. 245:1981;1230-1232
53. Javaheri ST, Parker J, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med. 335:1996;562-567
54. Guilleminault C, Hayes B. Naloxone, theophylline, bromocriptine, and obstructive sleep apnea: Negative results. Bull Eur Physiopathol Respir. 19:1983;632-634
55. Mulloy E, McNichols WT. Theophylline in obstructive sleep apnea: A double-blind evaluation. Chest. 101:1992;753-757
56. Orr WC, Males JL, Imes NK. Myxedema and obstructive sleep apnea. Am J Med. 70:1981;1061-1066
57. Rajagopal KR, Abbrecht PH, Derderian SS, et al. Obstructive sleep apnea in hypothyroidism. Ann Intern Med. 101:1984;491-494
58. Grunstein RR, Sullivan CE. Sleep apnea and hypothyroidism: Mechanisms and management. Am J Med. 85:1988;775-779
59. Gothe B, Strohl KP, Levin S, et al. Nicotine: A different approach to treatment of obstructive sleep apnea. Chest. 87:1985;11-17
60. Davilla DG, Hunt RD, Offord KP, et al. Acute effects of transdernal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med. 150:1994;469-474
61. Suratt PM, Wilhoit SC, Brown ED, et al. Effect of doxapram on obstructive sleep apnea. Bull Eur Physiopathol Respir. 22:1986;127-131
62. Atkinson RL, Suratt PM, Recant L. Naloxone improves sleep apnea in obese patients. Int J Obes. 9:1986;233-239
63. Whyte KF, Gould GA, Airlie MA, et al. Role of protriptylline and acetozolamide in the sleep apnea/hypopnea syndrome. Sleep. 11:1988;463-472
64. Tojima H, Kunitomo F, Kimura H, et al. Effects of acetozolamide in patients with sleep apnea syndrome. Sleep. 11:1988;463-472
65. Cartwright R, Stefoski D, Caldarelli D, et al. Toward a treatment logic for sleep apnea: The place of the tongue retaining device. Behav Res Ther. 26:1988;121-126
66. Lowe AA, Murat O, Miyamoto K, et al. A randomized trial to compare nCPAP and an oral appliance for the treatment of obstructive sleep apnea. Sleep Res. 25:1996;515. (abstr)
67. Schmidt-Nowara WW, Meade TE, Hays MB. Treatment of snoring and obstructive sleep apnea with a dental orthosis. Chest. 99:1991;1378-1385
68. Menn SJ, Loube DI, Morgan TD, et al. The mandibular repositioning device: Role in the treatment of obstructive sleep apnea. Sleep. 19:1996;794-800
69. Bonham PE, Currier GF, Orr WC, et al. The effect of a modified functional appliance on obstructive sleep apnea. Am J Orthod Dentofacial Orthop. 94:1988;384-392
70. Eveloff SE, Rosenberg CL, Carlisle CC, et al. Efficacy of a Herbst mandibular advancement device in obstructive sleep apnea. Am J Respir Crit Care Med. 155:1997;1748-1754
71. Millman RP, Rosenberg CL, Kramer NR. Oral appliances in the treatment of snoring and sleep apnea. Clin Chest Med. 19:1998;69-75
72. Smith DS. A three-dimensional airway assessment for the treatment of the snoring and/or sleep apnea with jaw repositioning intraoral appliances: A case study. J Craniomandibular Pract. 14:1996;332-343
73. Loube DI. Oral appliance treatment for obstructive sleep apnea. Clin Pulm Med. 5:1998;124-128
74. Schonhofer B, Stoohs RA, Rager H, et al. A new tongue advancement technique for sleep-disordered breathing. Am J Respir Crit Care Med. 155:1996;732-738
75. Schmidt-Nowara WW, Lowe A, Wiggand L, et al. Oral Appliances for the treatment of snoring and obstructive sleep apnea: A review. Sleep. 18:1995;501-510
76. Jamieson AO, Thornton WK, Forester MD, et al. Progressive mandibular protrusion during sleep in sleep apnea: A pilot study with an adjustible mandibular positioner. Sleep Res. 23:1994;445. (abstr)
77. Ferguson KA, Ono T, Lowe AA, et al. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest. 109:1996;1269-1275
78. Clark GT, Blumenfeld I, Yoffe N, et al. A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest. 109:1996;1477-1483
79. American Sleep Disorders Association Standards of Practice Committee, Thorpy M, (chair). Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. Sleep. 18:1995;511-513
80. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet. 1:1981;862-865
81. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March, 1994. Am J Respir Crit Care Med. 150:1994;1738-1745
82. Rapoport DM. Methods to stabilize the upper airway using positive pressure. Sleep. 19:1996;S123-S130. (suppl)
83. Guilleminault C, Stoohs R, Clerk A, et al. From obstructive sleep apnea syndrome to upper airways resistance syndrome: Consistency of daytime sleepiness. Sleep. 15:1992;S13-S16. (suppl)
84. Iber C, O'Brian C, Schluter J, et al. Single night studies in obstructive apnea. Sleep. 14:1991;383-385
85. Sanders MH, Kern NB, Costantino JP, et al. Adequacy of prescribing positive airway pressure therapy by mask for sleep apnea on the basis of a partial-night trial. Am Rev Respir Dis. 147:1993;1169-1174
86. Yamashiro Y, Kryger MH. CPAP titration for sleep apnea using a split-night protocol. Chest. 107:1995;62-66
87. Miljeteig H, Hoffstein V. Determinants of continuous positive airway pressure level for treatment in obstructive sleep apnea. Am Rev Respir Dis. 147:1993;1526-1530
88. Hoffstein V, Mateika S. Predicting nasal continuous positive airway pressure. Am J Respir Crit Care Med. 150:1994;486-488
89. Coppola MP, Lawee M. Management of obstructive sleep apnea syndrome in the home: The role of portable sleep apnea recording. Chest. 104:1993;19-25
90. Stiller RA, Strollo PJ, Sanders MH. Unattended recording in the diagnosis and treatment of sleep-disordered breathing: Unproven accuracy, untested assumptions, and unready for routine use. Chest. 105:1994;1306-1308
91. Juház J, Schillen J, Urbigkeit A, et al. Unattended continuous positive airway pressure titration: Clinical relevance and cardiorespiratory hazards of the method. Am J Respir Crit Care Med. 154:1996;359-365
92. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 147:1993;887-895
93. Weaver TE, Kribbs NB, Pack AI, et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep. 20:1997;278-283
94. Sanders MH, Kern NB, Stiller RA, et al. CPAP therapy via oronasal mask for obstructive sleep apnea. Chest. 106:1994;774-779
95. Mortimore IL, Whittle AT, Douglas NJ. Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax. 53:1998;290-292
96. Strollo PJ. Practical aspects of CPAP therapy for sleep apnea. Rose BD. Up To Date (6.2). Pulm Crit Care Med. 1998;. [electronic media]
97. Edinger JD, Radtke RA. Use of in vivo desensitization to treat a patient's claustrophobic response to nasal CPAP. Sleep. 16:1993;678-680
98. Sanders MH, Kern N. Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Chest. 98:1990;317-324
99. Reeves-Hoche MK, Hudgel DW, Meck R, et al. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med. 151:1995;443-449
100. Sharma S, Wali S, Pouliot Z, et al. Treatment of obstructive sleep apnea with a self-titrating continuous positive airway pressure. Sleep. 19:1996;497-501
101. Teschler H, Berthon-Jones M, Thompson AB, et al. Automated continuous positive airway pressure titration for obstructive sleep apnea. Am J Respir Crit Care. 154:1996;734-740
102. Scharf MB, Brannen DE, McDannold MD, et al. Computerized adjustable versus fixed NCPAP treatment of obstructive sleep apnea. Sleep. 19:1996;491-494
103. Teschler H, Berthon-Jones M, Wessendorf T, et al. Automated continuous positive airway pressure titration for obstructive sleep apnea. Am J Respir Crit Care Med. 154:1996;734-740
104. Stradling JR, Barbour C, Pitson DJ, et al. Automatic nasal continuous positive airway pressure titration in the laboratory: Patient outcomes. Thorax. 52:1996;72-75
105. Berkani M, Lofaso F, Chouaid C, et al. CPAP titration by an auto-CPAP device based on snoring detection: a clinical trial and economic considerations. Eur Respir J. 12:1998;759-763
106. LÉvy P, Pepin J-L. Auto-CPAP: An effective and low-cost procedure in the management of OSAS? Eur Respir J. 12:1998;753-755
107. Series F, Marc I. Efficiency of automatic continuous positive airway pressure therapy that uses an estimated required pressure in the treatment of the obstructive sleep apnea syndrome. Ann Intern Med. 127:1997;588-595
108. Strollo PJ Jr, Sanders MH, Atwood CW. Positive pressure therapy. Clin Chest Med. 19:1998;55-68
109. Bahamman A, Kryger M. Decision making in obstructive sleep-disordered breathing. Putting it all together. Clin Chest Med. 19:1998;87-97